The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival results by the prospectively determined clinical staging for locally advanced gastric cancer: An ancillary study of JCOG1302A (JCOG1302A2).
 
Tsutomu Hayashi
No Relationships to Disclose
 
Junki Mizusawa
Employment - Pfizer (I)
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Tadayoshi Hashimoto
No Relationships to Disclose
 
Takeo Fukagawa
No Relationships to Disclose
 
Rie Makuuchi
No Relationships to Disclose
 
Makoto Hikage
No Relationships to Disclose
 
Kazunari Misawa
No Relationships to Disclose
 
Takanobu Yamada
Honoraria - BMS; Johnson & Johnson/Janssen; Ono Pharmaceutical; Taiho Pharmaceutical
 
Takashi Nomura
No Relationships to Disclose
 
Yasuyuki Kawachi
No Relationships to Disclose
 
Takahiro Kinoshita
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Medtronic; Olympus Medical Systems; Otsuka; Taiho Pharmaceutical; TERUMO; Tsumura & Co.
Travel, Accommodations, Expenses - Bristol-Myers Squibb Japan; Daiichi Sankyo; Johnson & Johnson K.K; Kaken Pharmaceutical; Lilly Japan; Medtronic; Olympus Medical Systems; Otsuka; Taiho Pharmaceutical
 
Ryohei Kawabata
Research Funding - Daiichi Sankyo/UCB Japan (Inst)
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Takeshi Sano
Honoraria - Daiichi Sankyo; Johnson & Johnson; Ono Pharmaceutical
 
Mitsuru Sasako
Honoraria - Daiichi Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical
 
Takaki Yoshikawa
Honoraria - AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; EA Pharma; Johnson & Johnson/Janssen; Medtronic; Miyarisan pharmaceutical; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; TERUMO
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Daiichi-Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)